Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

SnagRx vs Wellorithm

SnagRx
Graded #387

Higher grade

vs+9.399999999999999
Wellorithm
Graded #486

Lower grade

The verdict

SnagRx takes it — 57.9/100 to 48.5/100.

SnagRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. SnagRx is a cash-pay GLP-1 telehealth service from Modern Metabolic Medicine, Inc.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSnagRx +6
36
30
Dose & formulationWellorithm +28
64
92
Clinical oversightSnagRx +48
76
28
Labs & monitoringSnagRx +13
53
40
FulfillmentSnagRx +9
71
62
Contract termsSnagRx +10
55
45
SnagRx · left barWellorithm · right bar

The numbers

MetricSnagRxWellorithm
WeighScore57.9/10048.5/100
GradeCC
Scorecard rank#387#486
Semaglutide$299/mo (starting dose, compounded)Pricing not published
Tirzepatide$399/mo (starting dose, compounded)Pricing not published
CoverageCoverage not published49 states (not Louisiana)
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
SnagRx

Graded #387 · C

Strengths

  • Compounded semaglutide ($99/mo) and tirzepatide ($149/mo) on launch discount, flat-priced at every dose
  • Names four partner pharmacies in Terms (RedRock, Health Warehouse, Precision Compounding, Triad Rx)
  • Available in all 50 states plus Washington D.C. per Terms
  • Telemed visit, prescription and free 1-2 day shipping included; no insurance or membership
  • Cancel anytime; full refund if disqualified by the medical provider

Where it loses points

  • Headline $99/$149 prices are discounted from $299/$399 standard; a countdown timer pressures signup
  • No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only
  • Refunds only available before medication is ordered; all sales otherwise final
  • Binding JAMS arbitration under Delaware law; class-action waiver
Wellorithm

Graded #486 · C

Strengths

  • Both molecules in BOTH routes — compounded semaglutide and tirzepatide as injections and as oral dissolving tablets
  • Four branded pens on the same account: Mounjaro, Ozempic, Wegovy and Zepbound
  • Sermorelin offered alongside the GLP-1 line
  • 24/7 phone support on a published number

Where it loses points

  • No price appears anywhere on the public site — /pricing 404s and every product CTA leads to a 2-minute intake quiz, so no cost can be compared before signing up
  • The site contradicts itself on coverage: the homepage says "Serving All 50 States" while its own FAQ says 49 states and excludes Louisiana
  • The four clinicians presented as "board-certified obesity specialists" are listed as Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery — none in obesity medicine
  • "100% Customer Satisfaction" is stated as a headline fact and is not a substantiable claim

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard